Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain
- PMID: 35612493
- PMCID: PMC9225399
- DOI: 10.1089/can.2022.0006
Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain
Abstract
The brain mechanism of inflammatory pain is an understudied area of research, particularly concerning the descending pain modulatory system. The G protein-coupled receptor 55 (GPR55) is a lysophosphatidylinositol-sensitive receptor that has also been involved in cannabinoid signaling. It is widely expressed throughout the central nervous system, including the periaqueductal gray (PAG), a brainstem area and key element of the descending pain modulatory system. In this study, we used behavioral, stereotaxic injections, pharmacological tools, and two inflammatory pain models (formalin and carrageenan) to determine if GPR55 in the PAG plays a role in the pain associated with inflammation in rats. It was found that the blockade of GPR55 action in PAG can drive the descending pain modulatory system to mitigate inflammatory pain. These data show that GPR55 plays a role in the descending pain modulatory system in inflammatory pain.
Keywords: GPR55; cannabinoids; descending pain modulatory system; inflammatory pain; periaqueductal gray.
Conflict of interest statement
No competing financial interests exist.
Figures


Similar articles
-
GPR55 in the brain and chronic neuropathic pain.Behav Brain Res. 2021 May 21;406:113248. doi: 10.1016/j.bbr.2021.113248. Epub 2021 Mar 18. Behav Brain Res. 2021. PMID: 33745983
-
Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.Naunyn Schmiedebergs Arch Pharmacol. 2020 Mar;393(3):371-379. doi: 10.1007/s00210-019-01735-x. Epub 2019 Oct 22. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 31641818
-
Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats.Neurosci Lett. 2021 Nov 1;764:136218. doi: 10.1016/j.neulet.2021.136218. Epub 2021 Sep 3. Neurosci Lett. 2021. PMID: 34487839
-
GPR55 - a putative "type 3" cannabinoid receptor in inflammation.J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):297-302. doi: 10.1515/jbcpp-2015-0080. J Basic Clin Physiol Pharmacol. 2016. PMID: 26669245 Review.
-
GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?Curr Top Med Chem. 2010;10(8):799-813. doi: 10.2174/156802610791164229. Curr Top Med Chem. 2010. PMID: 20370712 Review.
Cited by
-
The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain.iScience. 2024 Nov 22;27(12):111409. doi: 10.1016/j.isci.2024.111409. eCollection 2024 Dec 20. iScience. 2024. PMID: 39717086 Free PMC article. Review.
-
Functional Changes of White Matter Are Related to Human Pain Sensitivity during Sustained Nociception.Bioengineering (Basel). 2023 Aug 21;10(8):988. doi: 10.3390/bioengineering10080988. Bioengineering (Basel). 2023. PMID: 37627873 Free PMC article.
-
KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats.J Pharmacol Exp Ther. 2024 Oct 18;391(2):231-240. doi: 10.1124/jpet.124.002190. J Pharmacol Exp Ther. 2024. PMID: 39134424
-
Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance.Cancers (Basel). 2022 Nov 24;14(23):5793. doi: 10.3390/cancers14235793. Cancers (Basel). 2022. PMID: 36497277 Free PMC article. Review.
References
-
- Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 1991;14:219–245. - PubMed
-
- Ossipov MH, Lai J, Malan TP Jr. et al. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci. 2002;909:12–24. - PubMed
-
- Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319–325. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical